Trial Profile
A randomized, open-label, cross-over drug interaction study to evaluate the effects of desvenlafaxine (DVS SR) and paroxetine on the pharmacokinetics of desipramine in healthy subjects
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Apr 2009
Price :
$35
*
At a glance
- Drugs Desipramine (Primary) ; Desvenlafaxine (Primary) ; Paroxetine (Primary)
- Indications Generalised anxiety disorder; Major depressive disorder; Obsessive-compulsive disorders; Panic disorder; Post-traumatic stress disorders; Premenstrual dysphoric disorder; Social phobia; Vasomotor symptoms
- Focus Pharmacogenomic; Pharmacokinetics
- Sponsors Wyeth
- 09 Oct 2007 Status changed from recruiting to completed
- 18 Oct 2006 New trial record.